Vestnik On-line
Orenburg State University april 25, 2024   RU/EN
Headings of Vestnik
Pedagogics
Psychology
Other

Search
Vak
Антиплагиат
Orcid
Viniti
ЭБС Лань
Rsl
Лицензия Creative Commons

2015, № 12 (187)



Shavaleeva K.R., Aznabaev R.A. DRY EYE SYNDROME IN LASIK PLANNING: CAUSES AND METHODS OF DIAGNOSIS (REVIEW)Dry eye symptoms are fairly common in patients prior to LASIK, very often due to dry eye-associated contact lens intolerance leading patients to seek alternate methods of refractive error correction. This review presents the main causes of dry eye syndrome and methods for its diagnosis. The prevalence of dry eye symptoms prior to undergoing LASIK is estimated to be between 38 and 75 %. Post-LASIK, it has been widely shown that a majority of patients complain of dry eye symptoms, especially in the early postoperative period. Immediately after LASIK, 95 % of patients report some dry eye symptoms. Dry eye symptoms are reported in as high as 60 % of patients 1 month after LASIK. Post-LASIK dry eye usually peaks in the first few months after surgery, and then symptoms begin to improve in the vast majority of patients at 6–12 months after surgery. Despite this, in some patients dry eye syndrome is retained for a longer period, significantly reducing the quality of life after LASIK. Diagnostics of dry eye syndrome still presents significant challenges for the practicing physician. The heterogeneity of the causes of dry eye syndrome and the absence of "gold standard" diagnostic dictates the need to develop principles of forecasting its occurrence and differentiated pathogenetically oriented prevention dry eye syndrome at LASIK. Identifying preoperative dry eyes, and treatment in the perioperative time period, can lead to enhanced patient satisfaction and more accurate visual outcomes.Key words: LASIK, dry eye syndrome.

Download
References:

1. Сомов Е.Е. Синдромы слезной дисфункции (анатомо-физиологические основы, диагностика, клиника и лечение) / Е.Е. Сомов, В.А. Ободов // под ред. проф. Е.Е. Сомова. — СПб.: "Человек", 2011. — 160 с: ил.

2. Sutton GL, Kim P. Laser in situ keratomileusis in 2010 — a review. Clin Experiment Ophthalmol. 2010;38(2):192–210.

3. Yu EY, Leung A, Rao S, Lam DS. Effect of laser in situ keratomileusis on tear stability. Ophthalmology. 2000;107(12):2131–2135.

4. McGhee CN, Orr D, Kidd B, Stark C, Bryce IG, Anastas CN. Psychological aspects of excimer laser surgery for myopia: reasons for seeking treatment and patient satisfaction. Br J Ophthalmol.1996;80(10):874–879.

5. De Paiva C, Chen Z, Koch D, et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol.2006;141(3):438–445.

6. Melki SA, Azar DT. LASIK complications: etiology, management, and prevention. Surv Ophthalmol. 2001;46(2):95–116.

7. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J Cataract Refract Surg.2001;27(4):577–584.

8. Battat L, Macri A, Dursun D, Pflugfelder SC. Effects of laser in situkeratomileusis on tear production, clearance, and the ocular surface.Ophthalmology. 2001;108(7):1230–1235.

9. Toda I, Asano-Kato N, Komai-Hori Y, Tsubota K. Dry eye after laser in situ keratomileusis. Am J Ophthalmol. 2001;132(1):1–7.

10. Cogan, D.G. Corneoscleral lesions in periarteritis nodosa and Wegener's granulomatosis / D.G. Cogan // Trans. Am. Ophthalmol. Soc. 1955. — Vol. 53.-P. 321.

11. CuIter, W.M. The ocular manifestation of lethal midline granuloma (Wegener's granulomatosis) / W.M. Culter, I.M. Blatt // Am. J. Ophthalmol. 1956. — Vol. 42.-P. 21.

12. Lee, S.-H. Rose bengal staining and cytologic characteristics associated with lipid tear deficiency / S.-H. Lee, S.C.G. Tseng // Am. J. Ophthalmol. 1997. -Vol. 124.-P. 736-750.

13. Полунин, Г.С. Особенности клинического течения различных форм синдрома "сухого глаза" основа для разработки адекватных методов лечения / Г.С. Полунин, Т.Н. Сафонова, Е.Г. Полунина // Вестн. офтальмологии. — 2006. — Т. 122, № 5. — С. 17-20.

14. Руководство по внутренним болезням / под ред. Е.И.Чазова. М.: Медицина, 1997.

15. Chen, H. Structure and composition of rat precorneal tear film: a study by an in vitro cryofixation. / H. Chen, S. Yamabayashi, Y. Tanaka et al. // Invest. Ophthalmol. Vis. Sci. 1997. — Vol. 38. — P. 381-387.

16. Beuerman R.W., Maitchouk D.Y., Varnell R.J. et. al. Interaction between lacrimal function and the ocular surface. // The Hague. Netherlands. Kugler publ. 1998. P. 1-10.

17. Murube J., Wilson S., Ramos-Esteban J. The important developments in dry eye. // Highlights of Ophthalmology. 2001. — v. 29. — №5 — P. 54-66.

18. Dartt DA. Interaction of EGF family growth factors and neurotransmitters in regulating lacrimal gland secretion. // Exp Eye Res. 2004 Mar;78(3):337-45.

19. Dartt D.A. Neuroregulation of tear secretion. // Ophthalmic Research. 2001. 34/SI/01.-P.101.

20. Knop E., Knop N., Brewitt H. Dry eye disease as a complex dysregulation of the functional anatomy of the regular surface. New concepts for understanding dry eye disease. // Soc. Esp. oftalmol. 2003. — v. 78 (11) — P. 595-602.

21. Stern M.E., Gao J., Siemasko K.F., Benerman R.W. et. al. The role of lacrimal functional unit in the pathophysiology of dry eye. // Exp. Res. 2004. v.78 (3) — P. 409-416.

22. Бржеский В.В., Сомов Е.Е. Синдром "сухого глаза": болезнь цивилизации. // Consilium provisorum. 2002. т. 2. — №4. — С. 12-15.

23. Shin SY, Lee YJ. Conjunctival changes induced by LASIK suction ring in a rabbit model. Ophthalmic Res. 2006;38(6):343–349.

24. Solomon R, Donnenfeld ED, Perry HD. The effects of LASIK on the ocular surface. Ocul Surf. 2004;2(1):34–44.

26. Lee JB, Ryu CH, Kim J, Kim EK, Kim HB. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg. 2000;26(9):1326–1331.

26. Novae G.D. Symposium on dry eye diagnosis and treatment. // Ophthalmology World News. 1995. — v. 1 — №5. — P. 20.

27. Auw-Haedrich C, Feltgen N. Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters. // Graefes Arch Clin Exp Ophthalmol. 2003 Sep;241(9):705-9.

28. Taner P, Akarsu C, Atasoy P, Bayram M, Ergin A. The effects of hormone replacement therapy on ocular surface and tear function tests in postmenopausal women. // Ophthalmologica. 2004 Jul-Aug;218(4):257-9.

29. Pelit A, Bagis T, Kayaselcuk F, Dursun D, Akova Y, Aydin P. Tear function tests and conjunctival impression cytology before and after hormone replacement therapy in postmenopausal women. // Eur J Ophthalmol. 2003 May;13(4):337-42.

30. Sullivan DA, Sullivan BD, Evans JE, Schirra F, at al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. // Ann N Y Acad Sci. 2002 Jun;966:211-22.

31. Sullivan D.A., Schirra F., Sullivan B.D. et.al. Sex steroid regulation of meibomian gland function. // Ophthalmic Research. 2002. — 34/SI/02. — P.144.

32. Shimmura S., Shimazaki J., Tsubota K. Results of a population-based questionnaire on the Symptoms and lifestyles associated with dry eyes. // Cornea. 1999. v. 18. — P. 408-411.

33. Brewitt H., Sistani F. Dry eye disease: the scale of the problem. // Surv. Ophthalmol. 2001. v. 45. Suppl.2. — S. 199-202.

34. Shein O.D., Munoz В., Tielsch J.M. et. al. Prevalen of dry eye among the elderly. // Am. J. Ophthalmol. 1997, v. 124. — P. 723-728.

35. Бржеский В.В., Сомов Е.Е. Роговично-конъюнктивальный ксероз (диагностика, клиника, лечение). // Изд. 2-е. СПб. 2003. — 119 С.

36. Acosta M.C., Tan M., Belmonte С et. al. Cornea and conjunctiva sensitivity relation with the dry eye. // Ophthalmic Research. 2001. — 34/SI/01. — P.101.

37. Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. // Curr Opin Ophthalmol. 2004 Aug;15(4):299-304.

38. Майчук Ю.Ф., Вахова Е.С, Майчук Д.Ю., Миронкова Е.А., Яни Е.В. Алгоритмы лечения острых инфекционных конъюнктивитов, направленные на предупреждение развития синдрома сухого глаза. // Пособие для врачей. Минздрав РФ. М. 2004. — 21 С.

39. Keijser S., Van-Best J.A., Van-der-Lelij A. et. al. Reflex and steady state tears in patients with latent stromal herpetic keratitis. // Invest. Ophthalmol. Vis. Sci. 2002. v. 43(1). — P.87-91.

40. Bron A.J. Blepharitis and the ocular surface. // 5 th Int. Symp. on Ocular Pharmacology and Therapeutics. Monaco. 2004. — P. A16.

41. Glasson MJ, Hseuh S, Willcox MD. Preliminary tear film measurements of tolerant and non-tolerant contact lens wearers. // Clin Exp Optom. 1999 Sep;82(5):177-181.

42. Thai LC, Tomlinson A, Simmons PA. In vitro and in vivo effects of a lubricant in a contact lens solution. // Ophthalmic Physiol Opt. 2002 Jul;22(4):319-29.

43. Petroll WM, Kovoor T, Ladage PM, Cavanagh HD, Jester JV, Robertson DM. Can postlens tear thickness be measured using three-dimensional in vivo confocal microscopy? // Eye Contact Lens. 2003 Jan;29(1 Suppl):S110-4; S1158, S192-4.

44. Nichols JJ, King-Smith PE. The impact of hydrogel lens settling on the thickness of the tears and contact lens. // Invest Ophthalmol Vis Sci. 2004 Aug;45(8):254954.

45. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. // Drug Saf. 2002;25(1):33-55.

46. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. // JAMA. 2001 Nov 7;286(17):2114-9.

47. Schroder C, Sieg P, Framme C, Honnicke K, Hakim SG, Geerling G. The submandibular gland in absolute dry eyes. Effect on the ocular surface. // Klin Monatsbl Augenheilkd. 2002 Jul;219(7):494-501.

48. Suzuki M, Massingale ML, Ye F, et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(9):4557–4561.

49. Albietz JM, McLennan SG, Lenton LM. Ocular surface management of photorefractive keratectomy and laser in situ keratomileusis. J Refract Surg.2003;19(6):636–644.

50. Tanaka M, Takano Y, Dogru M, et al. Effect of preoperative tear function on early functional visual acuity after laser in situ keratomileusis. J Cataract Refract Surg. 2004;30(11):2311–2315.


About this article

Authors: Shavaleeva K.R., Aznabaev R.A.

Year: 2015


Editor-in-chief
Sergey Aleksandrovich
MIROSHNIKOV

Crossref
Cyberleninka
Doi
Europeanlibrary
Googleacademy
scienceindex
worldcat
© Электронное периодическое издание: ВЕСТНИК ОГУ on-line (VESTNIK OSU on-line), ISSN on-line 1814-6465
Зарегистрировано в Федеральной службе по надзору в сфере связи, информационных технологий и массовых коммуникаций
Свидетельство о регистрации СМИ: Эл № ФС77-37678 от 29 сентября 2009 г.
Учредитель: Оренбургский государственный университет (ОГУ)
Главный редактор: С.А. Мирошников
Адрес редакции: 460018, г. Оренбург, проспект Победы, д. 13, к. 2335
Тел./факс: (3532)37-27-78 E-mail: vestnik@mail.osu.ru
1999–2024 © CIT OSU